Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 29;25(1):155.
doi: 10.1186/s13063-024-07993-2.

Integrated exercise program in opioid agonist therapy clinics and effect on psychological distress: study protocol for a randomized controlled trial (BAReAktiv)

Einar Furulund  1   2   3 , Tesfaye Madebo  4   5 , Karl Trygve Druckrey-Fiskaaen  4   6 , Jørn Henrik Vold  4   6   7 , Mette Hegland Nordbotn  4 , Eivin Dahl  8 , Sindre M Dyrstad  9 , Torgeir Gilje Lid  10   11 , Lars T Fadnes  4   6 ; ATLAS4LAR study group
Collaborators, Affiliations

Integrated exercise program in opioid agonist therapy clinics and effect on psychological distress: study protocol for a randomized controlled trial (BAReAktiv)

Einar Furulund et al. Trials. .

Abstract

Background: Substance use disorder is associated with unhealthy lifestyle choices, resulting in adverse social and health consequences. People with opioid use disorder receiving opioid agonist therapy, in particular, have high morbidity and reduced quality of life. Physical activity is recommended as an adjunctive treatment for people with substance use disorder, but there is minimal evidence from randomized controlled trials on the effects of this among people with substance use disorder receiving opioid agonist therapy.

Methods: BAReAktiv is a multicentre randomized controlled trial. The study aims to recruit 324 patients receiving opioid agonist therapy (parallel groups randomized 1:1 to integrated exercise intervention or control, superiority trial). A 16-week group-based integrated exercise intervention with workouts twice a week. The exercise program consists of endurance and resistance training. The target group will be patients 18 years and older receiving opioid agonist therapy in outpatient clinics in several centers in Western Norway. The primary outcome of the study is the effect on psychological distress measured by Hopkins' symptom checklist with ten items. Secondary outcome measures include physical functioning assessed with a 4-min step test, activity level, fatigue symptoms, quality of life, and changes in inflammation markers. This study will provide improved knowledge on the effects of an integrated exercise program in opioid agonist therapy.

Discussion: Systematically integrating exercise programs for people receiving opioid agonist therapy could lead to a shift towards a stronger focus on health behaviors in outpatient care. Integrating exercise could benefit patient recovery and reduce disease burden. Further scale-up will be considered if the provided exercise program is safe and effective.

Trial registration: ClinicalTrials.gov. NCT05242848. Registered on February 16, 2022.

Keywords: Behavioral intervention; Exercise therapy; Intervention; Motor activity; Opiate substitution treatment; Outpatient; Substance-related disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Illustrates the timing of the intervention and follow-up for the study. *Measurements are timed as indicated by the arrows
See this image and copyright information in PMC

References

    1. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379(9810):55–70. doi: 10.1016/S0140-6736(11)61138-0. - DOI - PubMed
    1. Jeynes KD, Gibson EL. The importance of nutrition in aiding recovery from substance use disorders: a review. Drug Alcohol Depend. 2017;179:229–239. doi: 10.1016/j.drugalcdep.2017.07.006. - DOI - PubMed
    1. GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–71. doi: 10.1016/S0140-6736(14)61682-2. - DOI - PMC - PubMed
    1. Aas CF, Vold JH, Gjestad R, Skurtveit S, Lim AG, Gjerde KV, et al. Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway. Subst Abuse Treat Prev Policy. 2021;16(1):20. doi: 10.1186/s13011-021-00354-1. - DOI - PMC - PubMed
    1. Aas CF, Vold JH, Skurtveit S, Lim AG, Ruths S, Islam K, et al. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway. Subst Abuse Treat Prev Policy. 2020;15(1):68. doi: 10.1186/s13011-020-00309-y. - DOI - PMC - PubMed

Publication types

Substances

Associated data